Pharmacy Fall Conference - 2014

Expanding Our Armamentarium Against Gram-Positive Infections: An Update on Newly Approved Antimicrobials

Activity Details
  • Credit Type: CPE
  • Credit Amount: 1.00
  • Cost: $5.00
  • Release: Feb 9, 2015
  • Expires: Oct 23, 2017
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    ( Ratings)


Harrison Bachmeier Harrison Bachmeier, PharmD
Internal Medicine Clinical Pharmacist
UK Chandler Hospital
Lexington, Kentucky

Needs Statement

Resistant gram positive organisms are a continuing threat related to both community-onset and hospital-acquired infections. Three new antimicrobial agents have been recently approved against resistant pathogens and each agent presents a unique challenge in order to ensure its proper use in clinical practice.

Target Audience



Upon Completion of this activity Pharmacist will be able to:

1. Recognize the impact of antimicrobial resistance related to gram-positive infections
2. Describe the pharmacology of newly approved antimicrobial agents
3. Identify their clinical utility and the potential role in therapy


ACPEThe University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned UAN 0022-0000-15-010-H01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Faculty Disclosure

Harrison Bachmeier, PharmD (Speaker) has no relevant financial relationships with commercial interests.

Harrison Bachmeier does intend to discuss the off-label use of a product.

No planners have any relevant financial relationships to disclose.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.